Effect of Albendazole in combination with Ivermectin in treatment of soil transmitted heminthiasis
- Conditions
- Health Condition 1: K639- Disease of intestine, unspecified
- Registration Number
- CTRI/2022/01/039738
- Lead Sponsor
- MANKIND PHARMA LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Children in the age group of 6-15 years attending the schools
selected for the study.
2. Parents willing to provide written informed consent to
participate in the trial and assent from children aged 7 and
above.
1. Presence of any major severe systemic illness, chronic severe
anaemia
2. History of epileptic disorders, visual disturbances, chronic
headache
3. Current use of anti-epileptics
4. Any subject febrile on the day of enrolment
5. Presence of any acute illness, vomiting, headache etc. on the
day of enrolment
6. Recent use of anti-helmintic drugs through governmentâ??s mass
drug administration program within the past 3 months in both
the study subject and any household contacts
7. Known allergy to the study medications
8. Current use of drugs known to have pharmacological interaction with Albendazole or Ivermectin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method